2026 Updated Verified RAC-GS dumps Q&As – Pass Guarantee or Full Refund [Q11-Q28]

admin
May 19, 2026

2026 Updated Verified RAC-GS dumps Q&As – Pass Guarantee or Full Refund [Q11-Q28]

5/5 - (2 votes)

2026 Updated Verified RAC-GS dumps Q&As – Pass Guarantee or Full Refund

RAC-GS PDF Questions and Testing Engine With 100 Questions

NEW QUESTION 11
Following the introduction of a new regulation, an evaluation of the company’s products by the regulatory
affairs professional indicates that 60 percent do not comply with the regulation.
What should the regulatory affairs professional do FIRST to meet the new requirement?

Contact the trade association for advice.

Communicate with the relevant internal departments.

Prepare documents for the files.

Request a permanent waiver from the new regulation.

NEW QUESTION 12
A company is developing a new line of products in an area that is new to the company. What is the BEST
approach?

Ask the trade association representative to provide an overview of the new product area to the
marketing team.

Obtain competitor research and provide the information to the management team.

Obtain regulatory documents and history and provide the information to R&D.

Summarize regulatory documents and history and provide the information to the management team.

NEW QUESTION 13
Which of the following is MOST appropriate for the purpose of lot release of biologics?

Inventory control

Safety assurance

Efficacy confirmation

Quality verification

NEW QUESTION 14
Which of the following criteria is MOST appropriate to define the animal species needed for the
pre-clinical toxicity testing of a biotechnology product?

Proposed dose and volume of administration

Biological activity with species and/or tissue specificity

Immunochemical and functional tests

Proposed product route and frequency of administration

NEW QUESTION 15
According to ICH, which of the following components of study information is NOT required in a clinical
study report?

Randomization scheme and codes

Protocol and protocol amendments

List of lECs or lRBs

Detailed CV of all investigators

NEW QUESTION 16
Which of the following is NOT considered a serious adverse event in a cardiovascular clinical trial?

Subject is hospitalized due to complications of the product administration.

Subject is hospitalized for the purpose of product administration.

Subject’s hospitalization is due to an unscheduled hip operation.

Subject’s hospitalization is prolonged during the clinical trial.

NEW QUESTION 17
Which of the following is the PRIMARY purpose of an audit report?

To carry out a complete review of product applications

To define how to prepare new product submissions

To document compliance history

To train sales representatives

NEW QUESTION 18
You discover that your company’s top selling product in the last two years has been used off-label. The
off-label use is estimated to be about 70%, and it has been consistent since the product was first released
to the market. Which of the following is MOST appropriate?

Discuss with regulatory authorities to investigate how to have the off-label indication approved.

No action is required since it is an off-label use.

Advise the senior management to send a “Dear Dr.” letter.

File a report to regulatory authorities and advise the marketing department to prevent future off-label
use.

NEW QUESTION 19
Which of the following is an example of an acceptable statement for an advertisement of an approved
arthritis medication?

“Product X is a guaranteed cure for arthritis.”

“Product X is effective for the treatment of arthritis.”

“Product X is safe for arthritis and without side effects.”

“Product X is effective in all patients with arthritis.”

NEW QUESTION 20
Which analysis method is MOST appropriate to prioritize risk and monitor the effectiveness of risk control
activities for a medical device?

Fishbone analysis

Failure modes, effects, and criticality analysis

Fault tree analysis

Quality by design analysis

NEW QUESTION 21
Which of the following changes to a drug product is MOST likely to be implemented without prior
regulatory authority approval?

Deleting an ingredient of the drug product

Deleting a drug substance

Introducing a new analytical method

Strengthening a precaution to the product labeling

NEW QUESTION 22
Which of the following is NOT required to be included in a marketing application?

Final printed label

Quality, safety, and efficacy Information

Administrative forms

Evidence of fee payment

NEW QUESTION 23
Which of the following BEST describes the process of post-marketing surveillance for healthcare
products?

Systematic procedure to review published scientific journals

Systematic procedure to review experiences with the products in use

Vigilance procedure to ensure the full traceability of the products

Vigilance procedure to notify the regulatory authorities about serious incidents

NEW QUESTION 24
After submission to the regulatory authority, a substantial error was found in the application. In order to
resolve this issue, what should be done FIRST?

Resubmit the entire package.

Inform upper management immediately.

Contact the legal department and ask them how to proceed.

Verify the procedure in the regulation for the corrections.

NEW QUESTION 25
The requirements for document control are located in which of the following documents?

ICH guidelines

IEC 60601

ISO 13485

WHO guidelines

NEW QUESTION 26
Which of the following is the BEST approach for mitigating potential regulatory compliance issues at your
company?

Document any failure to follow regulatory compliance processes in employee performance reviews.

Develop documented procedures for regulatory compliance processes and train personnel.

Train all new employees on regulatory compliance processes and assign a mentor to them.

Train employees on all regulatory compliance processes using state-of-the-art systems.

NEW QUESTION 27
As part of the regulatory strategy for companies intending to manufacture a psychotropic product, which
of the following approvals should be received FIRST?

Site license

Product license

Import license

Export license

NEW QUESTION 28
What is the LAST stage in the development of a quality risk management process for a medical device?

Risk analysis

Risk reduction

Risk acceptance

Risk evaluation

Loading …